ArticleCancer biomarkers : section A of Disease markers2021

Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years).

Maja Sirotković-Skerlev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.